Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Tan

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2023
Conditional Astrocyte Rac1KO Attenuates Hyperreflexia after Spinal Cord InjuryCurtis A Benson, Kai-Lan Olson, Siraj Patwa, et al.
Scientific Reports|April 10, 2021
Conditional RAC1 knockout in motor neurons restores H-reflex rate-dependent depression after spinal cord injuryCurtis A Benson, Kai-Lan Olson, Siraj Patwa, et al.
The Journal of Physiology|September 4, 2024
PAK1 inhibition with Romidepsin attenuates H-reflex hyperexcitability after spinal cord injurySierra D Kauer, Curtis A Benson, Jennifer M Carrara, et al.
Journal of Huntington'S Disease|February 20, 2025
Antidopaminergic medications in Huntington's diseaseAndrew M Tan, Michal Geva, Y Paul Goldberg, et al.
Brain : a Journal of Neurology|August 25, 2020
Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodyniaLubin Chen, Jianying Huang, Curtis Benson, et al.
Patterns (New York, N.Y.)|November 21, 2024
A FAIR, open-source virtual reality platform for dendritic spine analysisMarike L Reimer, Sierra D Kauer, Curtis A Benson, et al.
Brain Communications|January 9, 2026
Mesenchymal stem cells reverse disease-specific abnormalities in nociceptive regions of the brainRyunosuke Fukushi, Masanori Sasaki, Hisashi Obara, et al.
CNS Drugs|March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's DiseaseYigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2023
Conditional Astrocyte Rac1KO Attenuates Hyperreflexia after Spinal Cord InjuryCurtis A Benson, Kai-Lan Olson, Siraj Patwa, et al.
Scientific Reports|April 10, 2021
Conditional RAC1 knockout in motor neurons restores H-reflex rate-dependent depression after spinal cord injuryCurtis A Benson, Kai-Lan Olson, Siraj Patwa, et al.
The Journal of Physiology|September 4, 2024
PAK1 inhibition with Romidepsin attenuates H-reflex hyperexcitability after spinal cord injurySierra D Kauer, Curtis A Benson, Jennifer M Carrara, et al.
Journal of Huntington'S Disease|February 20, 2025
Antidopaminergic medications in Huntington's diseaseAndrew M Tan, Michal Geva, Y Paul Goldberg, et al.
Brain : a Journal of Neurology|August 25, 2020
Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodyniaLubin Chen, Jianying Huang, Curtis Benson, et al.
Patterns (New York, N.Y.)|November 21, 2024
A FAIR, open-source virtual reality platform for dendritic spine analysisMarike L Reimer, Sierra D Kauer, Curtis A Benson, et al.
Brain Communications|January 9, 2026
Mesenchymal stem cells reverse disease-specific abnormalities in nociceptive regions of the brainRyunosuke Fukushi, Masanori Sasaki, Hisashi Obara, et al.
CNS Drugs|March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's DiseaseYigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Pageof 5